Perstorp, a Swedish chemicals business backed by PAI Partners, has sold its Capa division to Ingevity for €590m.
GPs will sell their entire interest in the share capital of Altran for €14 per share
Vendors Zwanenberg and René Hochstenbach will retain minority stakes following the acquisition
Fund will target seed and series-A opportunities in technology sectors across Europe
Company plans to increase its revenues and to double its network of clinics by 2021